Sign inGet started

Bruno Julianne

Insider CIK 2019645 · CRSP Chief Operating Officer · DMRA Director

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
DMRA Damora Therapeutics, Inc. A Award deriv2026-03-232026-03-2537,313— $037,313SEC↗
GLTO Galecto, Inc. M Exercise deriv2026-02-092026-02-12129— $00SEC↗
GLTO Galecto, Inc. M Exercise2026-02-092026-02-12129,000— $0137,032SEC↗
CRSP CRISPR Therapeutics AG S Sale2025-03-212025-03-241,714$41.23 $70.7K10,544SEC↗
CRSP CRISPR Therapeutics AG M Exercise deriv2025-03-202025-03-243,750— $011,250SEC↗
CRSP CRISPR Therapeutics AG M Exercise2025-03-202025-03-243,750— $012,258SEC↗
CRSP CRISPR Therapeutics AG A Award deriv2025-03-142025-03-1836,666— $036,666SEC↗
CRSP CRISPR Therapeutics AG A Award deriv2025-03-142025-03-1827,500— $027,500SEC↗
CRSP CRISPR Therapeutics AG S Sale2025-03-122025-03-12190$43.32 $8.2K8,508SEC↗
CRSP CRISPR Therapeutics AG M Exercise deriv2025-03-112025-03-12435— $00SEC↗
CRSP CRISPR Therapeutics AG M Exercise2025-03-112025-03-12435— $08,698SEC↗
CRSP CRISPR Therapeutics AG S Sale2025-03-112025-03-121,198$42.42 $50.8K8,263SEC↗
CRSP CRISPR Therapeutics AG M Exercise deriv2025-03-102025-03-122,399— $04,796SEC↗
CRSP CRISPR Therapeutics AG M Exercise2025-03-102025-03-122,399— $09,461SEC↗
CRSP CRISPR Therapeutics AG S Sale2025-02-192025-02-19333$52.80 $17.6K7,062SEC↗
CRSP CRISPR Therapeutics AG M Exercise deriv2025-02-182025-02-19650— $0650SEC↗
CRSP CRISPR Therapeutics AG M Exercise2025-02-182025-02-19650— $07,395SEC↗
CRSP CRISPR Therapeutics AG A Award deriv2024-10-162024-10-1818,333— $018,333SEC↗
CRSP CRISPR Therapeutics AG S Sale2024-06-212024-06-243,366$56.09 $188.8K6,745SEC↗
CRSP CRISPR Therapeutics AG M Exercise deriv2024-06-202024-06-247,000— $00SEC↗
CRSP CRISPR Therapeutics AG M Exercise2024-06-202024-06-247,000— $010,111SEC↗
CRSP CRISPR Therapeutics AG A Award deriv2024-05-232024-05-2420,000— $020,000SEC↗